US Bancorp DE Boosts Holdings in Danaher Corporation $DHR

US Bancorp DE lifted its position in shares of Danaher Corporation (NYSE:DHR) by 1.5% during the third quarter, HoldingsChannel reports. The firm owned 578,898 shares of the conglomerate’s stock after purchasing an additional 8,557 shares during the quarter. US Bancorp DE’s holdings in Danaher were worth $114,773,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in DHR. White Pine Capital LLC lifted its holdings in Danaher by 1.4% in the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after buying an additional 49 shares in the last quarter. SOL Capital Management CO increased its position in shares of Danaher by 2.8% during the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock worth $363,000 after acquiring an additional 50 shares during the last quarter. Purkiss Capital Advisors LLC lifted its stake in shares of Danaher by 3.9% in the third quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock worth $263,000 after acquiring an additional 50 shares in the last quarter. TCTC Holdings LLC boosted its holdings in Danaher by 0.7% in the third quarter. TCTC Holdings LLC now owns 7,439 shares of the conglomerate’s stock valued at $1,475,000 after purchasing an additional 51 shares during the last quarter. Finally, Howard Capital Management Group LLC grew its stake in Danaher by 4.8% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock valued at $230,000 after purchasing an additional 53 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Price Performance

DHR opened at $209.35 on Friday. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The company’s 50-day moving average price is $225.62 and its 200 day moving average price is $216.09. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The firm has a market cap of $148.04 billion, a price-to-earnings ratio of 41.54, a price-to-earnings-growth ratio of 2.83 and a beta of 0.91.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating the consensus estimate of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the company earned $2.14 earnings per share. As a group, sell-side analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a $0.40 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s dividend payout ratio is 31.75%.

Analyst Ratings Changes

DHR has been the topic of a number of recent analyst reports. Jefferies Financial Group upped their target price on Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Robert W. Baird set a $251.00 target price on shares of Danaher in a research report on Thursday, January 29th. Morgan Stanley started coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price target on the stock. Finally, HSBC boosted their price objective on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Monday, December 1st. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Insider Transactions at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.